학술논문

HSV‐1 ICP27 targets the TBK1‐activated STING signalsome to inhibit virus‐induced type I IFN expression
Document Type
article
Source
The EMBO Journal. 35(13)
Subject
Emerging Infectious Diseases
Sexually Transmitted Infections
HIV/AIDS
Infectious Diseases
2.2 Factors relating to the physical environment
Aetiology
Infection
Cells
Cultured
Herpesvirus 1
Human
Host-Pathogen Interactions
Humans
Immediate-Early Proteins
Immune Evasion
Interferon Type I
Macrophages
Membrane Proteins
Protein Interaction Mapping
Protein Serine-Threonine Kinases
herpes simplex virus
immune evasion
innate immunity
type I IFN
Biological Sciences
Information and Computing Sciences
Medical and Health Sciences
Developmental Biology
Language
Abstract
Herpes simplex virus (HSV) 1 stimulates type I IFN expression through the cGAS-STING-TBK1 signaling axis. Macrophages have recently been proposed to be an essential source of IFN during viral infection. However, it is not known how HSV-1 inhibits IFN expression in this cell type. Here, we show that HSV-1 inhibits type I IFN induction through the cGAS-STING-TBK1 pathway in human macrophages, in a manner dependent on the conserved herpesvirus protein ICP27. This viral protein was expressed de novo in macrophages with early nuclear localization followed by later translocation to the cytoplasm where ICP27 prevented activation of IRF3. ICP27 interacted with TBK1 and STING in a manner that was dependent on TBK1 activity and the RGG motif in ICP27. Thus, HSV-1 inhibits expression of type I IFN in human macrophages through ICP27-dependent targeting of the TBK1-activated STING signalsome.